{
    "laboratory_examinations": [
        {
            "procedure_name": "IGF-I and IGFBP3 levels",
            "date": "Not specified",
            "findings": "Before receiving GH therapy, IGF-I levels were 67 ng/ml (normal range, 56–144 ng/ml) and IGFBP3 levels were 1.7 mg/liter (normal range, 0.9–3.0 mg/liter). During GH therapy, IGF-I levels ranged from 156 to 598 ng/ml (mean values for normal girls age 4–6 yr, 138–172 ng/ml) and IGFBP3 levels ranged from 3.0 to 6.0 mg/liter (mean values for normal girls age 4–6 yr, 2.1 to 3.0 mg/liter).",
            "changes_over_time": "IGF-I levels increased significantly during GH therapy."
        },
        {
            "procedure_name": "Skinfold thickness measurements",
            "date": "Not specified",
            "findings": "Skinfold thickness at peripheral sites such as triceps, thigh, and calf was below the 10th percentile. Some truncal skinfolds, such as axillary, subscapular, and suprailiac, were below the 10th percentile; however, chest and abdominal skinfold thicknesses were close to the 50th percentile.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Plasma insulin and leptin levels",
            "date": "Not specified",
            "findings": "Serum leptin level was 1.6 ng/ml (normal values from 5th to 95th percentile, 1.2 to 6.6 ng/ml), and insulin level was 1.1 U/ml (normal value, 0–13 U/ml).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Serum triglyceride concentration",
            "date": "At the age of 2 yr and 10 months",
            "findings": "Serum triglyceride concentration was 127 mg/dl, and high-density lipoprotein cholesterol was 37 mg/dl.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Blood analysis (chemistry and lipoprotein levels)",
            "date": "Not specified",
            "findings": "Metabolic assessment revealed normal fasting glucose (79 mg/dl) concentration. Serum total cholesterol and low-density lipoprotein cholesterol were in the normal range.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Mutational analysis of LMNA and ZMPSTE24 genes",
            "date": "Not specified",
            "findings": "The mutational analysis revealed a homozygous p.Arg527Cys (c.1579 C/T) mutation in exon 9 in the patient. No mutations were noted in the ZMPSTE24 gene.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Immunoblotting of skin fibroblast lysates",
            "date": "Not specified",
            "findings": "No prelamin A accumulation was identified in the patient's fibroblast lysate.",
            "changes_over_time": "Not specified."
        }
    ]
}